Change in obesity-related metabolic abnormalities associated with body mass index improvement through life-style intervention: A meta-regression.
BMI-SDS
insulin resistance
meta-regression
metabolic health
obesity
Journal
Pediatric diabetes
ISSN: 1399-5448
Titre abrégé: Pediatr Diabetes
Pays: Denmark
ID NLM: 100939345
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
22
02
2019
revised:
28
08
2019
accepted:
07
11
2019
pubmed:
11
12
2019
medline:
17
2
2021
entrez:
11
12
2019
Statut:
ppublish
Résumé
The reduction in body mass index standard deviation score (BMI-SDS) associated with improvement in biomarkers relating to metabolic health in obese children is unknown. We aimed to establish the change in BMI-SDS associated with improved inflammation, liver function, and insulin resistance to inform clinical guidelines for pediatric weight management interventions and to assess the efficacy of future trials. A large-scale systematic review was conducted to identify relevant studies. Studies of children with a diagnosis of obesity according to defined BMI thresholds, participating in lifestyle interventions to reduce obesity, were included. Studies must have reported baseline (pre-) and postintervention (or change of) BMI-SDS and either fasting glucose, homeostatic model of insulin resistance (HOMA-IR), alanine aminotransferase (ALT), C-reactive protein (CRP), or interleukin-6 (IL-6). A series of meta-regressions were conducted to establish links between BMI-SDS change scores and change in metabolic markers of health. Sixty-eight articles were identified. From the meta-regression analyses, across all study subsets, greater mean falls in all four parameters, (HOMA-IR, Glucose, ALT, and CRP) were observed with greater mean loss of BMI-SDS, but the trends were only statistically significant for HOMA-IR and CRP (P = .003; P = .021). However, we could not find minimum changes in BMI-SDS that would ensure a fall in these outcomes. At this time, we are unable to recommend a definitive value of BMI-SDS reduction needed to improve the markers of metabolic health. Future trials should aim to report additional indices of derived BMI values, which may better reflect changes in actual adiposity.
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
173-193Subventions
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Abarca-Gómez L, Abdeen ZA, Hamid ZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642.
Weiss R, Caprio S. The metabolic consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab. 2005;19(3):405-419.
Sahoo K, Sahoo B, Choudhury AK, Sofi NY, Kumar R, Bhadoria AS. Childhood obesity: causes and consequences. J Fam Med Prim Care. 2015;4(2):187-192.
Withrow D, Alter DA. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev. 2011;12(2):131-141.
Van Gaal LF, Mertens IL, Ballaux D. What is the relationship between risk factor reduction and degree of weight loss? Eur Heart J Suppl. 2005;7(suppl_L):L21-L26.
Cole TJ, Green PJ. Smoothing reference centile curves: the lms method and penalized likelihood. Stat Med. 1992;11(10):1305-1319.
Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol. 2008;159(Suppl 1):S67-S74.
Levy-Marchal C, Arslanian S, Cutfield W, et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab. 2010;95(12):5189-5198.
Ford AL, Hunt LP, Cooper A, Shield JP. What reduction in BMI SDS is required in obese adolescents to improve body composition and cardiometabolic health? Arch Dis Child. 2010a;95(4):256-261.
Reinehr T, Kiess W, Kapellen T, Andler W. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics. 2004;114(6):1569-1573.
Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediat Inflamm. 2010;2010:1-10.
DeBoer MD. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition. 2013;29(2):379-386.
Valle Jimenez M, Estepa RM, Camacho RM, Estrada RC, Luna FG, Guitarte FB. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol. 2007;156(4):497-502.
Sirico F, Bianco A, D'Alicandro G, et al. Effects of physical exercise on adiponectin, leptin, and inflammatory markers in childhood obesity: systematic review and meta-analysis. Child Obes. 2018;14(4):207-217.
Stolzman S, Bement MH. Inflammatory markers in Pediatric obesity: health and physical activity implications. Infant Child Adole Nutri. 2012;4(5):297-302.
Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679-689.
Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS ONE. 2015;10(10):e0140908.
Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846-854.
Burgert TS, Taksali SE, Dziura J, et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006;91(11):4287-4294.
Utz-Melere M, Targa-Ferreira C, Lessa-Horta B, Epifanio M, Mouzaki M, Mattos AA. Non-alcoholic fatty liver disease in children and adolescents: lifestyle change - a systematic review and meta-analysis. Ann Hepatol. 2018;17(3):345-354.
Birch L, Perry R, Hunt LP, et al. What change in body mass index is associated with improvement in percentage body fat in childhood obesity? A meta-regression. BMJ Open. 2019;9(8):e028231. https://doi.org/10.1136/bmjopen-2018-028231.
Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess. 2004;8(21):iii-iv. 1-182.
Stata v15 (StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC)
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. https://doi.org/10.1186/1471-2288-14-135.
Ford AL, Bergh C, Sodersten P, et al. Treatment of childhood obesity by retraining eating behaviour: randomised controlled trial. BMJ. 2010b;340:b5388.
Aeberli I, Jung A, Murer SB, et al. During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat. J Clin Endocrinol Metab. 2010;95(12):5412-5418.
Murer SB, Knopfli BH, Aeberli I, et al. Baseline leptin and leptin reduction predict improvements in metabolic variables and long-term fat loss in obese children and adolescents: a prospective study of an inpatient weight-loss program. Am J Clin Nutr. 2011;93(4):695-702.
Bell LM, Watts K, Siafarikas A, et al. Exercise alone reduces insulin resistance in obese children independently of changes in body composition. J Clin Endocrinol Metab. 2007;92(11):4230-4235.
Bock DE, Robinson T, Seabrook JA, et al. The health initiative program for Kids (HIP Kids): effects of a 1-year multidisciplinary lifestyle intervention on adiposity and quality of life in obese children and adolescents-a longitudinal pilot intervention study. BMC Pediatr. 2014;14:296.
Bruyndonckx L, Hoymans VY, De Guchtenaere A, et al. Diet, exercise, and endothelial function in obese adolescents. Pediatrics. 2015;135(3):e653-e661. https://doi.org/10.1542/peds.2014-1577.
Bustos P, Orias J, Saez K, Maldonado M, Cuadra L, Asenjo S. Effects of the bright bodies program in Chilean obese children. Rev Med Chil. 2015;143(9):1136-1143.
Calcaterra V, Larizza D, Codrons E, et al. Improved metabolic and cardiorespiratory fitness during a recreational training program in obese children. J Pediatr Endocrinol Metab. 2013;26(3-4):271-276.
Corripio R, Gonzalez-Clemente JM, Perez-Sanchez J, et al. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study. Eur J Endocrinol. 2010;163(6):887-893.
Dobe M, Geisler A, Hoffmann D, et al. The Obeldicks concept. An example for a successful outpatient lifestyle intervention for overweight or obese children and adolescents. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011;54(5):628-635.
Farpour-Lambert NJ, Aggoun Y, Marchand LM, Martin XE, Herrmann FR, Beghetti M. Physical activity reduces systemic blood pressure and improves early markers of atherosclerosis in pre-pubertal obese children. J Am Coll Cardiol. 2009;54(25):2396-2406.
Ford AL, Bergh C, Sodersten P, et al. Treatment of childhood obesity by retraining eating behaviour: randomised controlled trial. BMJ (Clin Res Ed). 2009;340, b5388.
Gajewska J, Kurylowicz A, Mierzejewska E, et al. Complementary effects of genetic variations in LEPR on body composition and soluble leptin receptor concentration after 3-month lifestyle intervention in Prepubertal obese children. Nutrients. 2016;8(6).
Garanty-Bogacka B, Syrenicz M, Goral J, et al. Changes in inflammatory biomarkers after successful lifestyle intervention in obese children. Endokrynol Pol. 2011;62(6):499-505.
Gronbaek H, Lange A, Birkebaek NH, et al. Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. J Pediatr Gastroenterol Nutr. 2012;54(2):223-228.
Kazankov K, Moller HJ, Lange A, et al. The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children. Pediatr Obes. 2015;10(3):226-233.
Grulich-Henn J, Lichtenstein S, Horster F, Hoffmann GF, Nawroth PP, Hamann A. Moderate weight reduction in an outpatient obesity intervention program significantly reduces insulin resistance and risk factors for cardiovascular disease in severely obese adolescents. Int J Endocrinol. 2011;2011:541021.
Gunnarsdottir T, Einarsson SM, Njardvik U, et al. Family-based behavioral treatment for obese children - results and two year follow up. Laeknabladid. 2014;100(3):139-145.
Huang F. del-Rio-Navarro BE, de Castro GT, et al. weight loss induced by 6-month lifestyle intervention improves early endothelial activation and fibrinolysis in obese adolescents. Child Care Health Dev. 2011;37(3):377-384.
Huang F, Del-Rio-Navarro BE, Perez-Ontiveros JA, et al. Effect of six-month lifestyle intervention on adiponectin, resistin and soluble tumor necrosis factor-alpha receptors in obese adolescents. Endocr J. 2014;61(9):921-931.
Kalavainen M, Utriainen P, Vanninen E, Korppi M, Nuutinen O. Impact of childhood obesity treatment on body composition and metabolic profile. World J Pediatr. 2012;8(1):31-37.
Koot BG, van der Baan-Slootweg OH, Vinke S, et al. Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment. Int J Obes. 2016;40(1):51-57.
Mager DR, Iniguez IR, Gilmour S, Yap J. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). J Parenter Enter Nutr. 2015;39(1):73-84.
Makkes S, Renders CM, Bosmans JE, van der Baan-Slootweg OH, Hoekstra T, Seidell JC. One-year effects of two intensive inpatient treatments for severely obese children and adolescents. BMC Pediatr. 2016;16:120.
Marcano H, Fernández M, Paoli M, et al. Limited weight loss or simply no weight gain following lifestyle-only intervention tends to redistribute body fat, to decrease lipid concentrations, and to improve parameters of insulin sensitivity in obese children. Int J Pediatr Endocrinol. 2011;2011(1):241703-241703.
Martos R, Valle M, Morales RM, Canete R, Gascon F, Urbano MM. Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction biomarkers in obese prepubertal children after 9 months of body mass index SD score loss. Metabolism. 2009;58(8):1153-1160.
Meyer AA, Kundt G, Lenschow U, Schuff-Werner P, Kienast W. Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J Am Coll Cardiol. 2006;48(9):1865-1870.
Miraglia F, de Moraes Silveira CR, Gomes Beghetto M, dos Santos OF, de Mello ED. Behavior of adipokines after a year follow-up in the obesity outpatient clinic for children and adolescents. Behavior of adipokines after a year follow-up in the obesity outpatient clinic for children and adolescents. Nutr Hosp. 2015;32(4):1554-1559.
Montero D, Walther G, Perez-Martin A, et al. Effects of a lifestyle program on vascular reactivity in macro- and microcirculation in severely obese adolescents. J Clin Endocrinol Metab. 2014;99(3):1019-1026.
Morell-Azanza L, Garcia-Calzon S, Rendo-Urteaga T, et al. Serum oxidized low-density lipoprotein levels are related to cardiometabolic risk and decreased after a weight loss treatment in obese children and adolescents. Pediatr Diabetes. 2017;18(5):392-398.
Rendo-Urteaga T, Garcia-Calzon S, Gonzalez-Muniesa P, et al. Peripheral blood mononuclear cell gene expression profile in obese boys who followed a moderate energy-restricted diet: differences between high and low responders at baseline and after the intervention. Br J Nutr. 2015;113(2):331-342.
Murdolo G, Tortoioli C, Celi F, et al. Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: a population-based survey in prepubertal schoolchildren. Endocrine. 2017;56(2):357-365.
Obert P, Gueugnon C, Nottin S, et al. Impact of diet and exercise training-induced weight loss on myocardial mechanics in severely obese adolescents. Obesity (Silver Spring). 2013;21(10):2091-2098.
Pacifico L, Arca M, Anania C, Cantisani V, Di Martino M, Chiesa C. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2013;23(10):1010-1016.
Panagiotopoulos C, Ronsley R, Al-Dubayee M, et al. The centre for healthy weights-shapedown BC: a family-centered, multidisciplinary program that reduces weight gain in obese children over the short-term. Int J Environ Res Public Health. 2011;8(12):4662-4678.
Parillo M, Licenziati MR, Vacca M, De Marco D, Iannuzzi A. Metabolic changes after a hypocaloric, low-glycemic-index diet in obese children. J Endocrinol Investig. 2012;35(7):629-633.
Racil G, Ben Ounis O, Hammouda O, et al. Effects of high vs. moderate exercise intensity during interval training on lipids and adiponectin levels in obese young females. Eur J Appl Physiol. 2013;113(10):2531-2540.
Racil G, Coquart JB, Elmontassar W, et al. Greater effects of high- compared with moderate-intensity interval training on cardio-metabolic variables, blood leptin concentration and ratings of perceived exertion in obese adolescent females. Biol Sport. 2016;33(2):145-152.
Rambhojan C, Bouaziz-Amar E, Larifla L, et al. Ghrelin, adipokines, metabolic factors in relation with weight status in school-children and results of a 1-year lifestyle intervention program. Nutr Metab. 2015;12(1):43.
Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab. 2004a;89(8):3790-3794.
Reinehr T, Andler W. Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child. 2004c;89(5):419-422.
Reinehr T, de Sousa G, Toschke AM, Andler W. Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr. 2006;84(3):490-496.
Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab. 2008a;93(11):4479-4485.
Reinehr T, Stoffel-Wagner B, Roth CL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab. 2008b;93(6):2287-2293.
Reinehr T, Schmidt C, Toschke AM, Andler W. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study. Arch Dis Child. 2009;94(6):437-442.
Reinehr T, Kleber M, Toschke AM. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis. 2009;207(1):174-180.
Reinehr T, Elfers C, Lass N, Roth CL. Irisin and its relation to insulin resistance and puberty in obese children: a longitudinal analysis. J Clin Endocrinol Metab. 2015;100(5):2123-2130.
Rijks JM, Plat J, Mensink RP, Dorenbos E, Buurman WA, Vreugdenhil AC. Children with morbid obesity benefit equally as children with overweight and obesity from an ongoing care program. J Clin Endocrinol Metab. 2015;100(9):3572-3580.
Rohrer TR, Rizzo VF, Casar JJ, et al. Changes in hepatic risk factors, metabolic variables, body composition, and physical fitness in obese children after a one-year weight loss program. J Pediatr Endocrinol Metab. 2008;21(9):837-845.
Roth CL, Kratz M, Ralston MM, Reinehr T. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism. 2011;60(4):445-452.
Roth CL, Elfers C, Lass N, Reinehr T. Betatrophin: no relation to glucose metabolism or weight status in obese children before and after lifestyle intervention. Pediatr Diabetes. 2017;18(6):485-491.
Feliu Rovira A, Paris Miro N, Zaragoza-Jordana M, et al. Clinical and metabolic effectiveness of a new motivational therapy for the treatment of obesity in adolescents (OBEMAT). An Pediatr (Barc). 2013;78(3):157-166.
Santomauro M, Paoli-Valeri M, Fernandez M, et al. Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle. Endocrinol Nutr. 2012;59(6):346-353.
Savoye M, Shaw M, Dziura J, et al. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA. 2007;297(24):2697-2704.
Savoye M, Nowicka P, Shaw M, et al. Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics. 2011;127(3):402-410.
Savoye M, Caprio S, Dziura J, et al. Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial. Diabetes Care. 2014;37(2):317-324.
Schum J, Blumenstock G, Weber K, et al. Variants of the FTO gene in obese children and their impact on body composition and metabolism before and after lifestyle intervention. Exp Clin Endocrinol Diabetes. 2012;120(3):128-131.
Seabra A, Katzmarzyk P, Carvalho MJ, et al. Effects of 6-month soccer and traditional physical activity programmes on body composition, cardiometabolic risk factors, inflammatory, oxidative stress markers and cardiorespiratory fitness in obese boys. J Sports Sci. 2016;34(19):1822-1829.
Shalitin S, Ashkenazi-Hoffnung L, Yackobovitch-Gavan M, et al. Effects of a twelve-week randomized intervention of exercise and/or diet on weight loss and weight maintenance, and other metabolic parameters in obese preadolescent children. Horm Res Paediatr. 2009;72(5):287-301.
Springer F, Ballweg V, Schweizer R, et al. Changes in whole-body fat distribution, intrahepatic lipids, and insulin resistance of obese adolescents during a low-level lifestyle intervention. Eur J Pediatr. 2015;174(12):1603-1612.
Truby H, Baxter K, Ware RS, et al. A randomized controlled trial of two different macronutrient profiles on weight, body composition and metabolic parameters in obese adolescents seeking weight loss. PLoS ONE. 2016;11(3):e0151787.
Uysal Y, Wolters B, Knop C, Reinehr T. Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention. Clin Nutr. 2014;33(4):620-625.
Valle Jimenez M, Martos R, Morales RM, et al. Relationship between changes in plasma leptin concentrations and plasminogen activator inhibitor-1 in obese prepubertal children after nine months of treatment. Ann Nutr Metab. 2013;63(3):216-222.
Van Hoorenbeeck K, Franckx H, Debode P, et al. Metabolic disregulation in obese adolescents with sleep-disordered breathing before and after weight loss. Obesity (Silver Spring). 2013;21(7):1446-1450.
van der Baan-Slootweg O, Benninga MA, Beelen A, et al. Inpatient treatment of children and adolescents with severe obesity in The Netherlands: a randomized clinical trial. JAMA Pediatr. 2014;168(9):807-814.
Verduci E, Radaelli G, Salvioni M, Riva E, Giovannini M. Plasma long-chain fatty acids profile and metabolic outcomes in normolipidaemic obese children after one-year nutritional intervention. Acta Paediatr. 2011;100(4):585-589.
Pozzato C, Verduci E, Scaglioni S, et al. Liver fat change in obese children after a 1-year nutrition-behavior intervention. J Pediatr Gastroenterol Nutr. 2010;51(3):331-335.
Verduci E, Lassandro C, Giacchero R, Miniello VL, Banderali G, Radaelli G. Change in metabolic profile after 1-year nutritional-Behavioral intervention in obese children. Nutrients. 2015;7(12):10089-10099.
Visuthranukul C, Sirimongkol P, Prachansuwan A, Pruksananonda C, Chomtho S. Low-glycemic index diet may improve insulin sensitivity in obese children. Pediatr Res. 2015;78(5):567-573.
Vitola BE, Deivanayagam S, Stein RI, et al. Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents. Obesity (Silver Spring). 2009;17(9):1744-1748.
Vos RC, Wit JM, Pijl H, Houdijk ECAM. Long-term effect of lifestyle intervention on adiposity, metabolic parameters, inflammation and physical fitness in obese children: a randomized controlled trial. Nutr Diabetes. 2011;1(10):e9.
Weiss R, Shaw M, Savoye M, Caprio S. Obesity dynamics and cardiovascular risk factor stability in obese adolescents. Pediatr Diabetes. 2009;10(6):360-367.
Evans RK, Franco RL, Stern M, et al. Evaluation of a 6-month multi-disciplinary healthy weight management program targeting urban, overweight adolescents: effects on physical fitness, physical activity, and blood lipid profiles. Int J Pediatr Obes. 2009;4(3):130-133.
Wickham EP, Stern M, Evans RK, et al. Prevalence of the metabolic syndrome among obese adolescents enrolled in a multidisciplinary weight management program: clinical correlates and response to treatment. Metab Syndr Relat Disord. 2009;7(3):179-186.
Wunsch R, de Sousa G, Toschke AM, Reinehr T. Intima-media thickness in obese children before and after weight loss. Pediatrics. 2006;118(6):2334-2340.
Tanner JM. Growth at Adolescence: with a General Consideration of the Effects of Hereditary and Environmental Factors upon Growth and Maturation from Birth to Maturity. 2nd ed. Blackwell Scientific: Oxford, England; 1962.
Elvsaas IK, Giske L, Fure B, Juvet LK. Multicomponent lifestyle interventions for treating overweight and obesity in children and adolescents: a systematic review and meta-analyses. J Obes. 2017;2017:5021902. https://doi.org/10.1155/2017/5021902.
Oude Luttikhuis H, Baur L, Jansen H, et al. Interventions for treating obesity in children. Cochrane Database Syst Rev. 2009;1:CD001872. https://doi.org/10.1002/14651858.CD001872.pub2.
Summerbell CD, Ashton V, Campbell KJ, Edmunds L, Kelly S, Waters E. Interventions for treating obesity in children (Review). Cochrane Database Syst Rev. 2003;3:1-58. https://doi.org/10.1002/14651858.CD001872.
Ho M, Garnett SP, Baur L, et al. Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis. Pediatrics. 2012;130(6):e1647-e1671.